Lilrevo Overview
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Lilrevo General Information
Description
Developer of HLA-targeted immunotherapy modalities designed to treat cancer and autoimmune diseases. The company is currently operating in Stealth mode.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
- Boston, MA
- United States
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Corporate Office
- Boston, MA
- United States
Lilrevo Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 01-Oct-2026 | Completed | Stealth |
Lilrevo Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Lilrevo Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Double Point Ventures | Venture Capital | Minority |
Lilrevo FAQs
-
Where is Lilrevo headquartered?
Lilrevo is headquartered in Boston, MA.
-
What industry is Lilrevo in?
Lilrevo’s primary industry is Other Healthcare Services.
-
Is Lilrevo a private or public company?
Lilrevo is a Private company.
-
What is Lilrevo’s current revenue?
The current revenue for Lilrevo is .
-
Who are Lilrevo’s investors?
Double Point Ventures has invested in Lilrevo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
